查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1612849

全球数位病理市场：产业分析、规模、占有率、成长、趋势和预测（2024-2031）

Digital Pathology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 177 Pages | 商品交期: 2-5个工作天内

价格
简介目录

重要见解

  • 数位病理市场规模（2024年）：80.5亿美元
  • 市场规模预测（2031年）：172亿美元
  • 全球市场成长率（2024-2031）：复合年增长率13.5%

市场成长动力：

全球数位病理学市场由几个关键因素推动，包括影像技术的进步、慢性病盛行率的增加以及远距医疗和远距诊断的日益普及。数位病理学解决方案提供更快、更准确、更有效率的诊断过程，使医疗保健提供者能够改善患者的治疗结果。数位病理系统中人工智慧和机器学习 (ML) 的整合提高了诊断准确性和工作流程效率。此外，对数位医疗技术的投资增加以及对改善医疗基础设施的需求也正在推动市场成长。

市场阻碍因素：

虽然数位病理市场正处于稳定成长的轨道上，但它也面临着初始设备成本高、与现有医疗系统整合的复杂性以及对资料隐私和安全性的担忧等课题。数位病理学解决方案在发展中地区的实施也因先进医疗技术的获取有限和缺乏熟练的专业人员而受到阻碍。为了在全球市场上充分发挥数位病理解决方案的潜力，需要解决这些障碍。

市场机会：

技术进步、医疗保健支出增加以及个人化医疗的扩张为该市场带来了巨大的成长机会。基于云端的平台、人工智慧驱动的诊断以及诊断成像技术的改进的整合都指向了新的成长途径。此外，对分子诊断、药物开发和研究应用的需求不断增长也为数位病理解决方案创造了巨大的商机。主要参与者、研究机构和医疗保健提供者之间的合作在推动数位病理技术的采用方面也发挥关键作用。

本报告调查了全球数位病理市场，并提供市场定义和概述、市场促进和阻碍因素、各种趋势、市场机会、课题、市场规模（数量和部分数量）趋势和预测，我们按不同类别/地区编製了详细分析/主要国家、竞争环境、主要企业概况等

目录

第1章执行摘要

第2章 市场概况

  • 市场范围和定义
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
    • 任务
    • 主要趋势
  • 宏观经济因素
    • 世界产业展望
    • 世界GDP成长展望
  • COVID-19 影响分析
  • 预测因素：相关性和影响

第3章增值见解

  • 产品采用分析
  • 监管状况
  • 价值链分析
  • 主要交易及合併
  • PESTLE分析
  • 波特五力分析
  • 母公司市场分析

第4章价格走势分析

  • 主要亮点
  • 影响产品价格的主要因素
  • 价格分析（按类型）
  • 区域定价和产品偏好

第5章全球数位病理市场展望：趋势与预测

  • 主要亮点
    • 市场规模预测
    • 市场规模/年成长率
    • 获利机会
  • 市场规模分析与预测
  • 全球数位病理市场展望：按产品
    • 市场规模趋势
    • 市场规模预测
    • 市场吸引力分析：产品
  • 全球数位病理市场展望：按应用分类
    • 市场规模趋势
    • 市场规模预测
    • 市场吸引力分析：产品
  • 全球数位病理学市场展望：按最终用户分类
    • 市场规模趋势
    • 市场规模预测
    • 市场吸引力分析：产品

第6章全球数位病理市场展望：按地区

  • 主要亮点
  • 市场规模趋势
  • 市场规模预测
    • 北美
    • 欧洲
    • 东亚
    • 南亚/大洋洲
    • 拉丁美洲
    • 中东/非洲
  • 市场吸引力分析：区域

第7章北美数位病理市场展望：趋势与预测

  • 主要亮点
  • 价格分析
  • 市场规模趋势
    • 按国家
    • 按产品
    • 按用途
    • 按最终用户
  • 市场规模分析/预测：按国家划分
    • 美国
    • 加拿大
  • 市场规模分析与预测：依产品分类
    • 数位病理设备
    • 数位病理软体
  • 市场规模分析与预测：依应用分类
    • 临床病理学
    • 分子诊断
    • 基础研究/应用研究
    • 药物开发
    • 其他
  • 市场规模分析/预测：按最终用户
    • 医院
    • 诊断实验室
    • 製药和生物技术公司
    • 法医研究所
    • 研究机构
    • 合约研究组织
    • 诊所
  • 市场吸引力分析

第8章欧洲数位病理市场展望：趋势与预测

  • 主要亮点
  • 价格分析
  • 市场规模趋势
  • 市场规模分析/预测：按国家划分
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 土耳其
    • 其他
  • 市场规模分析与预测：依产品分类
  • 市场规模分析与预测：依应用分类
  • 市场规模分析/预测：按最终用户
  • 市场吸引力分析

第9章东亚数位病理市场展望：趋势与预测

  • 主要亮点
  • 价格分析
  • 市场规模趋势
  • 市场规模分析/预测：按国家划分
    • 中国
    • 日本
    • 韩国
  • 市场规模分析与预测：依产品分类
  • 市场规模分析与预测：依应用分类
  • 市场规模分析/预测：按最终用户
  • 市场吸引力分析

第10章南亚与大洋洲数位病理市场展望：趋势与预测

  • 主要亮点
  • 价格分析
  • 市场规模趋势
  • 市场规模分析/预测：按国家划分
    • 印度
    • 东南亚
    • 澳洲
    • 其他
  • 市场规模分析与预测：依产品分类
  • 市场规模分析与预测：依应用分类
  • 市场规模分析/预测：按最终用户
  • 市场吸引力分析

第11章拉丁美洲数位病理市场展望：趋势与预测

  • 主要亮点
  • 价格分析
  • 市场规模趋势
  • 市场规模分析/预测：按国家划分
    • 巴西
    • 墨西哥
    • 其他
  • 市场规模分析与预测：依产品分类
  • 市场规模分析与预测：依应用分类
  • 市场规模分析/预测：按最终用户
  • 市场吸引力分析

第12章中东与非洲数位病理市场展望：趋势与预测

  • 主要亮点
  • 价格分析
  • 市场规模趋势
  • 市场规模分析/预测：按国家划分
    • 海湾合作委员会国家
    • 埃及
    • 南非
    • 北非
    • 其他
  • 市场规模分析与预测：依产品分类
  • 市场规模分析与预测：依应用分类
  • 市场规模分析/预测：按最终用户
  • 市场吸引力分析

第13章 竞争格局

  • 市场占有率分析
  • 市场结构
  • 公司简介（详细资料：概述、财务状况、策略、最新发展）
    • Leica Biosystems (Danaher Corporation)
    • F. Hoffmann-La Roche AG
    • Huron Technologies International Inc.
    • Koninklijke Philips N.V.
    • Olympus Corporation
    • Hamamatsu Photonics K.K.
    • Carl Zeiss AG
    • Nikon Corporation
    • 3DHISTECH Ltd.
    • Hologic Inc.
    • PerkinElmer, Inc.
    • Visiopharm
    • OptraSCAN, Inc.
    • Inspirata, Inc.

第14章附录

简介目录
Product Code: PMRREP33922

Persistence Market Research has recently released a comprehensive report on the global Digital Pathology Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Digital Pathology Market Size (2024E): USD 8.05 Bn
  • Projected Market Value (2031F): USD 17.2 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 13.5%

Digital Pathology Market - Report Scope:

Digital pathology refers to the acquisition, management, sharing, and interpretation of pathology information in a digital environment. The market includes various products and services, such as digital pathology equipment, software, and services, that enable the transformation of traditional microscopy and pathology workflows. The growing adoption of digital pathology solutions is driven by factors such as the increasing demand for accurate diagnostics, advancements in telepathology, and the need for efficient and scalable pathology systems in clinical, research, and pharmaceutical settings.

Market Growth Drivers:

The global digital pathology market is driven by several key factors, including advancements in imaging technology, the increasing prevalence of chronic diseases, and the growing adoption of telemedicine and remote diagnostics. Digital pathology solutions provide faster, more accurate, and more efficient diagnostic processes, enabling healthcare providers to improve patient outcomes. The integration of artificial intelligence (AI) and machine learning (ML) in digital pathology systems is enhancing diagnostic accuracy and workflow efficiency. Additionally, increasing investments in digital health technologies and the demand for improved healthcare infrastructure are fueling market growth.

Market Restraints:

Despite its promising growth, the digital pathology market faces challenges such as high initial investment costs for equipment, integration complexities with existing healthcare systems, and concerns about data privacy and security. Additionally, the adoption of digital pathology solutions in developing regions is hindered by limited access to advanced healthcare technologies and a lack of skilled professionals. These barriers need to be addressed to unlock the full potential of digital pathology solutions in global markets.

Market Opportunities:

The market presents significant growth opportunities driven by advancements in technology, increased healthcare spending, and the expansion of personalized medicine. The integration of cloud-based platforms, AI-driven diagnostics, and improved imaging techniques offers new avenues for growth. Moreover, the rising demand for molecular diagnostics, drug development, and research applications presents substantial opportunities for digital pathology solutions. Collaborations between key market players, research institutes, and healthcare providers will play a crucial role in advancing the adoption of digital pathology technologies.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the digital pathology market?
  • Which types of digital pathology products are witnessing the highest adoption across different regions?
  • How is the integration of AI and machine learning transforming the digital pathology landscape?
  • Who are the leading players in the digital pathology market, and what strategies are they employing to remain competitive?
  • What are the emerging trends and future prospects in the digital pathology market?

Competitive Intelligence and Business Strategy:

Leading players in the global digital pathology market, such as Danaher Corporation, F. Hoffmann-La Roche AG, and Koninklijke Philips N.V., are focusing on product innovation, strategic partnerships, and acquisitions to maintain their market leadership. These companies are investing heavily in research and development to create advanced digital pathology solutions that integrate AI, machine learning, and cloud technologies. Collaboration with healthcare providers, research institutes, and regulatory bodies is essential for market expansion and adoption. Furthermore, improving the interoperability of digital pathology systems with existing healthcare IT infrastructure is a key strategy for long-term growth.

Key Companies Profiled:

  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Huron Technologies International Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • Hamamatsu Photonics K.K.
  • Carl Zeiss AG
  • Nikon Corporation
  • 3DHISTECH Ltd.
  • Hologic Inc.
  • PerkinElmer, Inc.
  • Visiopharm

Digital Pathology Industry Research by Category:

By Product Type:

  • Digital Pathology Equipment
  • Digital Pathology Software
  • Digital Pathology Services

By Application:

  • Clinical Pathology
  • Molecular Diagnostics
  • Basic and Applied Research
  • Drug Development
  • Others

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Forensic Laboratories
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Clinics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Digital Pathology Market Snapshot, 2024 - 2031
  • 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Analysis
  • 3.7. Parent Market Analysis

4. Price Analysis, 2023A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
  • 5.3. Global Digital Pathology Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019 - 2023
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
      • 5.3.3.1. Digital Pathology Equipment
        • 5.3.3.1.1. Whole Slide Scanners
        • 5.3.3.1.1.1. Brightfield Slide Scanners
        • 5.3.3.1.1.2. Fluorescence Slide Scanners
        • 5.3.3.1.1.3. Combination Slide Scanners
        • 5.3.3.1.2. Clinical Microscope
        • 5.3.3.1.3. Tissue Microarrays
      • 5.3.3.2. Digital Pathology Software
        • 5.3.3.2.1. Image Viewing and Analysis Software
        • 5.3.3.2.2. Digital Pathology Information Systems
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Digital Pathology Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
    • 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
      • 5.4.3.1. Clinical Pathology
      • 5.4.3.2. Molecular Diagnostics
      • 5.4.3.3. Basic & Applied Research
      • 5.4.3.4. Drug Development
      • 5.4.3.5. Others
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Digital Pathology Market Outlook: End User
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Diagnostic Laboratories
      • 5.5.3.3. Pharmaceutical & Biotechnology Companies
      • 5.5.3.4. Forensic Laboratories
      • 5.5.3.5. Research Institutes
      • 5.5.3.6. Contract Research Organizations (CROs)
      • 5.5.3.7. Clinics
    • 5.5.4. Market Attractiveness Analysis: End User

6. Global Digital Pathology Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 7.4.1. Digital Pathology Equipment
      • 7.4.1.1. Whole Slide Scanners
        • 7.4.1.1.1. Brightfield Slide Scanners
        • 7.4.1.1.2. Fluorescence Slide Scanners
        • 7.4.1.1.3. Combination Slide Scanners
      • 7.4.1.2. Clinical Microscope
      • 7.4.1.3. Tissue Microarrays
    • 7.4.2. Digital Pathology Software
      • 7.4.2.1. Image Viewing and Analysis Software
      • 7.4.2.2. Digital Pathology Information Systems
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 7.5.1. Clinical Pathology
    • 7.5.2. Molecular Diagnostics
    • 7.5.3. Basic & Applied Research
    • 7.5.4. Drug Development
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic Laboratories
    • 7.6.3. Pharmaceutical & Biotechnology Companies
    • 7.6.4. Forensic Laboratories
    • 7.6.5. Research Institutes
    • 7.6.6. Contract Research Organizations (CROs)
    • 7.6.7. Clinics
  • 7.7. Market Attractiveness Analysis

8. Europe Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 8.4.1. Digital Pathology Equipment
      • 8.4.1.1. Whole Slide Scanners
        • 8.4.1.1.1. Brightfield Slide Scanners
        • 8.4.1.1.2. Fluorescence Slide Scanners
        • 8.4.1.1.3. Combination Slide Scanners
      • 8.4.1.2. Clinical Microscope
      • 8.4.1.3. Tissue Microarrays
    • 8.4.2. Digital Pathology Software
      • 8.4.2.1. Image Viewing and Analysis Software
      • 8.4.2.2. Digital Pathology Information Systems
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 8.5.1. Clinical Pathology
    • 8.5.2. Molecular Diagnostics
    • 8.5.3. Basic & Applied Research
    • 8.5.4. Drug Development
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic Laboratories
    • 8.6.3. Pharmaceutical & Biotechnology Companies
    • 8.6.4. Forensic Laboratories
    • 8.6.5. Research Institutes
    • 8.6.6. Contract Research Organizations (CROs)
    • 8.6.7. Clinics
  • 8.7. Market Attractiveness Analysis

9. East Asia Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 9.4.1. Digital Pathology Equipment
      • 9.4.1.1. Whole Slide Scanners
        • 9.4.1.1.1. Brightfield Slide Scanners
        • 9.4.1.1.2. Fluorescence Slide Scanners
        • 9.4.1.1.3. Combination Slide Scanners
      • 9.4.1.2. Clinical Microscope
      • 9.4.1.3. Tissue Microarrays
    • 9.4.2. Digital Pathology Software
      • 9.4.2.1. Image Viewing and Analysis Software
      • 9.4.2.2. Digital Pathology Information Systems
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 9.5.1. Clinical Pathology
    • 9.5.2. Molecular Diagnostics
    • 9.5.3. Basic & Applied Research
    • 9.5.4. Drug Development
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic Laboratories
    • 9.6.3. Pharmaceutical & Biotechnology Companies
    • 9.6.4. Forensic Laboratories
    • 9.6.5. Research Institutes
    • 9.6.6. Contract Research Organizations (CROs)
    • 9.6.7. Clinics
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 10.4.1. Digital Pathology Equipment
      • 10.4.1.1. Whole Slide Scanners
        • 10.4.1.1.1. Brightfield Slide Scanners
        • 10.4.1.1.2. Fluorescence Slide Scanners
        • 10.4.1.1.3. Combination Slide Scanners
      • 10.4.1.2. Clinical Microscope
      • 10.4.1.3. Tissue Microarrays
    • 10.4.2. Digital Pathology Software
      • 10.4.2.1. Image Viewing and Analysis Software
      • 10.4.2.2. Digital Pathology Information Systems
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 10.5.1. Clinical Pathology
    • 10.5.2. Molecular Diagnostics
    • 10.5.3. Basic & Applied Research
    • 10.5.4. Drug Development
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic Laboratories
    • 10.6.3. Pharmaceutical & Biotechnology Companies
    • 10.6.4. Forensic Laboratories
    • 10.6.5. Research Institutes
    • 10.6.6. Contract Research Organizations (CROs)
    • 10.6.7. Clinics
  • 10.7. Market Attractiveness Analysis

11. Latin America Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 11.4.1. Digital Pathology Equipment
      • 11.4.1.1. Whole Slide Scanners
        • 11.4.1.1.1. Brightfield Slide Scanners
        • 11.4.1.1.2. Fluorescence Slide Scanners
        • 11.4.1.1.3. Combination Slide Scanners
      • 11.4.1.2. Clinical Microscope
      • 11.4.1.3. Tissue Microarrays
    • 11.4.2. Digital Pathology Software
      • 11.4.2.1. Image Viewing and Analysis Software
      • 11.4.2.2. Digital Pathology Information Systems
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 11.5.1. Clinical Pathology
    • 11.5.2. Molecular Diagnostics
    • 11.5.3. Basic & Applied Research
    • 11.5.4. Drug Development
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic Laboratories
    • 11.6.3. Pharmaceutical & Biotechnology Companies
    • 11.6.4. Forensic Laboratories
    • 11.6.5. Research Institutes
    • 11.6.6. Contract Research Organizations (CROs)
    • 11.6.7. Clinics
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End User
  • 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 12.4.1. Digital Pathology Equipment
      • 12.4.1.1. Whole Slide Scanners
        • 12.4.1.1.1. Brightfield Slide Scanners
        • 12.4.1.1.2. Fluorescence Slide Scanners
        • 12.4.1.1.3. Combination Slide Scanners
      • 12.4.1.2. Clinical Microscope
      • 12.4.1.3. Tissue Microarrays
    • 12.4.2. Digital Pathology Software
      • 12.4.2.1. Image Viewing and Analysis Software
      • 12.4.2.2. Digital Pathology Information Systems
  • 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 12.5.1. Clinical Pathology
    • 12.5.2. Molecular Diagnostics
    • 12.5.3. Basic & Applied Research
    • 12.5.4. Drug Development
    • 12.5.5. Others
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 12.6.1. Hospitals
    • 12.6.2. Diagnostic Laboratories
    • 12.6.3. Pharmaceutical & Biotechnology Companies
    • 12.6.4. Forensic Laboratories
    • 12.6.5. Research Institutes
    • 12.6.6. Contract Research Organizations (CROs)
    • 12.6.7. Clinics
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Leica Biosystems (Danaher Corporation)
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. F. Hoffmann-La Roche AG
    • 13.3.3. Huron Technologies International Inc.
    • 13.3.4. Koninklijke Philips N.V.
    • 13.3.5. Olympus Corporation
    • 13.3.6. Hamamatsu Photonics K.K.
    • 13.3.7. Carl Zeiss AG
    • 13.3.8. Nikon Corporation
    • 13.3.9. 3DHISTECH Ltd.
    • 13.3.10. Hologic Inc.
    • 13.3.11. PerkinElmer, Inc.
    • 13.3.12. Visiopharm
    • 13.3.13. OptraSCAN, Inc.
    • 13.3.14. Inspirata, Inc.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations